{{Cite journal| doi = 10.1007/s00134-023-07141-5| issn = 1432-1238 (Electronic) 0342-4642 (Print) 0342-4642 (Linking)| volume = 49| issue = 7| pages = 831–839| last1 = Skrifvars| first1 = M. B.| last2 = Luethi| first2 = N.| last3 = Bailey| first3 = M.| last4 = French| first4 = C.| last5 = Nichol| first5 = A.| last6 = Trapani| first6 = T.| last7 = McArthur| first7 = C.| last8 = Arabi| first8 = Y. M.| last9 = Bendel| first9 = S.| last10 = Cooper| first10 = D. J.| last11 = Bellomo| first11 = R.| last12 = Epo-Tbi Investigators| first12 = the Anzics Clinical Trials Group| title = The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury| journal = Intensive Care Med| date = 2023-07-05| pmid = 37405413}}